focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.50
Bid: 38.00
Ask: 39.00
Change: -2.05 (-4.91%)
Spread: 1.00 (2.632%)
Open: 43.50
High: 39.70
Low: 39.70
Prev. Close: 41.75
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: MetalNRG hails Gold Ridge findings

Thu, 09th Nov 2023 13:47

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

MetalNRG PLC - London-based natural resources and energy-focused investor - Says results from geologic soil sampling programme at Gold Ridge property in Arizona, US "support its previous belief that there is a real possibility of a larger undiscovered gold/base metal system". Programme finds "strong gold, copper, lead and zinc mineralisation related to the Mascot Stock". There is also "Strong gold, silver, arsenic, lead and zinc mineralisation related to the Apache Pass Shear zone". Tests also show a new gold, copper, lead and zinc trend in the Precambrian block. Executive Director Rolf Gerritsen says: "We are delighted with these results which confirm that whilst there is follow up work to be carried out, there is a real gold and indeed wider opportunity at Gold Ridge."

----------

Panthera Resources PLC - gold explorer and developer with assets in India and West Africa - Australian unit Indo Gold Pty Ltd preparing to deliver notice of dispute to India's government. Delivery is expected in the fourth-quarter of the year. The dispute concerns an alleged breach by India of a treaty with Australia on the Promotion & Protection of Investments. Panthera adds: "Following the delivery of the notice of dispute and in the absence of any meaningful correspondence in relation to this matter from the government of India or if no amicable settlement is reached, IGPL will subsequently deliver a notice of arbitration to the government of India. Any such notice of arbitration is anticipated to be delivered to the government of India in the first quarter of 2024. Under the Treaty, an arbitral tribunal is to be constituted within two months of delivery of the notice of arbitration." Panthera also notes a Times of India report that the gold deposit at the Bhukia asset "could be worth over USD1 billion", based on information from the Geological Survey of India. Panthera adds: "This valuation has not been independently verified by the company. Accordingly, while at this stage the company is not able to make any comments in relation to the potential quantum of damages that IGPL will claim from India, the company will in due course, announce the actual quantum of damages that IGPL will claim from India when available."

Panthera first invested in Bhukia, via its Australian unit, back in January 2005. A prospecting licence at the asset was rejected by the government of Rajasthan in August 2018 on "various spurious and legally untenable grounds", according to Panthera. Under the terms of an act passed in India in 2021, Panthera believes it has the rights to "fair and equitable compensation, not merely reimbursement of expenditures".

----------

United Oil & Gas PLC - oil and gas company focused on Egypt and Jamaica - In Jamaica, it notes it is currently engaged in discussions with a preferred potential partner to work alongside United Oil in the Walton Morant licence. United Oil adds: "Furthermore, the company is engaging with the Jamaican authorities to secure an extension to the current licence period which expires at the end of January 2024, so as to provide sufficient time to progress additional technical work on the block to support the drilling of an exploration well." In Egypt, working interest production averages 1,024 barrels of oil equivalent per day for the year to November 5, in line with 2023 outlook between 930 to 1,030 boepd. United Oil adds: "The full-year guidance includes production from the current wells and contributions from workover activity currently being undertaken on the fields." It cautions that the macroeconomic environment in Egypt, characterised by reduced US dollar liquidity as deteriorated. Less US dollar liquidity has impacted its ability to repatriate funds from Egypt. "Whilst Egyptian General Petroleum Corp has continued to make regular payments to the company against the receivable balance, including Egyptian pound payments equivalent to USD1.8 million since the 31 October, no USD payments have been received since August 2023," United Oil says.

----------

PCI-PAL PLC - Suffolk, England-based global cloud provider of secure payment solutions for business communications - Revenue in financial year ended June 30 increases 25% to GBP14.9 million from GBP11.9 million. Pretax loss widens to GBP4.9 million from GBP3.1 million, however. Administrative expenses climb 37% to GBP17.9 million. Non-Executive Chair Simon Wilson says: "I continue to be both excited and encouraged by the progress that has been made by the group in FY23, and the board is confident in the outlook and prospects in FY24 and beyond. Given the momentum in the business I look forward to sharing further progress reports and news during the coming year, as we continue our strategic growth journey towards profitability and further scale."

----------

Concurrent Technologies PLC - Essex, England-based designer and manufacturer of computer boards - Launches its "highest performance plug in card" yet. The new offering has "enhanced operational performance unlocked using an emerging cooling technology". It adds: "Previously, the PIC was cooled via conduction, while the new variant uses air flowing through a heat exchanger built into the product. This heat exchanger has been optimised using thermal simulations and verified through extensive testing to ensure it operates at peak performance under harsh environmental conditions. The benefit for customers is that they can extract more performance from the same physical card."

----------

Sareum Holdings PLC - Cambridge, England-based biotechnology firm - Announces first dosing of patients in food effect part of phase 1a probe of autoimmune therapy SDC-1801. This portion of the study probes how food consumption changes, if at all, the efficacy of the product. It will help determine whether the product must be taken on an empty stomach, for example. SDC-1801 will have an initial focus on psoriasis, an autoimmune condition affecting the skin.

----------

Amala Foods PLC - cash shell - Shares in the company are temporarily suspended as it enters into a binding agreement that could lead to reverse takeover of healthcare firm Dialysis Care Plus Inc. DCP is "building dialysis centres in the Philippines where the market for dialysis services is growing substantially every year". Amala adds: "The team has an excellent track record with internationally known healthcare groups in the USA as well as locally in the Philippines. The valuation approach that is being considered is one whereby upon a successful transaction the valuation paid would be based upon a share consideration and a deferred share consideration determined by financial performance. The company expects to conclude matters shortly and will provide further updates to the market this month." For the half-year ended September 30, the company reports a pretax loss of GBP39,602, narrowing from GBP82,631 12 months earlier. Loss is solely down to administrative expenses, which fall 57% from GBP91,327.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
5 May 2023 15:53

Sareum gets approval for phase one psoriasis studies in Australia

(Sharecast News) - Biotechnology developer Sareum Holdings announced on Friday that it has been granted approval by Australia's Therapeutic Goods Administration (TGA) to conduct phase one clinical studies on SDC-1801.

Read more
5 May 2023 11:26

Sareum receives Australian approval for psoriasis drug clinical trial

Alliance News) - Sareum Holdings PLC on Friday said its application to start a phase 1 clinical trial in Australia of its lead product, psoriasis drug SDC-1801, has been approved.

Read more
5 May 2023 11:11

AIM WINNERS & LOSERS: Aptamer says struggling to convert pipeline

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
22 Mar 2023 11:47

Sareum Holdings interim loss widens as touts psoriasis candidate drug

(Alliance News) - Sareum Holdings PLC on Wednesday reported an increased half-year loss for the six months to December 31, as it continued to work on its psorasis candidate drug SDC-1801.

Read more
17 Mar 2023 18:06

IN BRIEF: Sareum makes trial application for SDC-1801 in Australia

Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune disease and cancer - On Wednesday, says it has begun an application to perform phase one clinical studies on SDC-1801 in Australia under the clinical trial notification scheme.

Read more
15 Mar 2023 15:43

UK earnings, trading statements calendar - next 7 days

Thursday 16 March 
Capital LtdFull Year Results
Centamin PLCFull Year Results
Deliveroo PLCFull Year Results
DFS Furniture PLCHalf Year Results
Empiric Student Property PLCFull Year Results
Eurocell PLCFull Year Results
FW ThorpeHalf Year Results (TBC)
Gelion PLCHalf Year Results
Gem Diamonds LtdFull Year Results
Gym Group PLCFull Year Results
Halma PLCTrading Statement
Helios Towers PLCFull Year Results
Hostmore PLCFull Year Results
Investec PLC and LtdTrading Statement
National World PLCFull Year Results
OSB Group PLCFull Year Results
PensionBee Group PLCFull Year Results
Polymetal International PLCfull Year Results
PYX Resources LtdFull Year Results
Rentokil Initial PLCFull Year Results
Restore PLCFull Year Results
Savills PLCFull Year Results
TI Fluid Systems PLCFull Year Results
WAG Payment Solutions PLCFull Year Results
Friday 17 March 
no events scheduled 
Monday 20 March 
Jubilee Metals Group PLCHalf Year Results
Tuesday 21 March 
Alliance Pharma PLCFull Year Results
Aptitude Software Group PLCFull Year Results
Boku IncFull Year Results
Diversified Energy Co PLCFull Year Results
Ergomed PLCFull Year Results
Fintel PLCFull Year Results
Gamma Communications PLCFull Year Results
Henry Boot PLCFull Year Results
Kape Technologies PLCFull Year Results
Kingfisher PLCFull Year Results
Luceco PLCFull Year Results
MP Evans Group PLCFull Year Results
Ocado Group PLCTrading Statement
Oxford Nanopore Technologies PLCFull Year Results
Pebble Group PLCFull Year Results
Quixant PLCFull Year Results
ScS Group PLCHalf Year Results
SThree PLCTrading Statement
Staffline Group PLCFull Year Results
Tissue Regenix Group PLCFull Year Results
Trustpilot Group PLCFull Year Results
YouGov PLCHalf Year Results
Zotefoams PLCFull Year Results
Wednesday 22 March 
Anpario PLCFull Year Results
Atalaya Mining PLCFull Year Results
BioPharma Credit PLCFull Year Results
Blackbird PLCFull Year Results
Bloomsbury Publishing PLCTrading Statement
Essentra PLCFull Year Results
Fevertree Drinks PLCFull Year Results
Genel Energy PLCFull Year Results
Gresham House PLCFull Year Results
Hostelworld Group PLCFull Year Results
Judges Scientific PLCFull Year Results
Kenmare Resources PLCFull Year Results
LSL Property Services PLCFull Year Results
Mpac Group PLCFull Year Results
NAHL Group PLCFull Year Results
Pendragon PLCFull Year Results
Pharos Energy PLCFull Year Results
Sareum Holdings PLCHalf Year Results
Ten Entertainment Group PLCFull Year Results
Tribal Group PLCFull Year Results
Vistry Group PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
6 Mar 2023 16:16

Sareum looks at options as GSK division returns cancer drug candidate

(Sharecast News) - Biotechnology developer Sareum announced on Monday that GSK subsidiary Sierra Oncology has returned clinical study reports and associated documents related to 'SRA737' to Sareum's co-development partner, the CRT Pioneer Fund.

Read more
6 Mar 2023 11:19

Sareum says GSK's Sierra returns clinical study reports to CRT Pioneer

(Alliance News) - Sareum Holdings PLC on Monday said that GSK PLC subsidiary Sierra Oncology Inc has completed the return of the clinical study reports relating to SRA737 to Sarerum's co-development partner CRT Pioneer Fund LP.

Read more
16 Dec 2022 21:53

TRADING UPDATES: Dev Clever to cancel shares; Tintra raises funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
16 Dec 2022 16:55

Sareum confident despite recent setbacks

(Sharecast News) - Autoimmune and cancer-focussed biotechnology company Sareum said in an update on Friday that it remained "confident" despite some recent setbacks.

Read more
16 Dec 2022 10:44

AIM WINNERS & LOSERS: Time Finance jumps on strong first-half results

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
9 Dec 2022 15:43

UK shareholder meetings calendar - next 7 days

Monday 12 December 
Devolver Digital IncSGM re 2022 Long-Term Incentive Plan approval
Marwyn Value Investors LtdAGM
Osirium Technologies PLCGM re placing agreement with Allenby Capital
PCF Group PLCGM re proposed cancellation of trading on AIM
Tuesday 13 December 
Amedeo Air Four Plus LtdAGM
Avation PLCAGM
Blancco Technology Group PLCAGM
JD Sports Fashion PLCGM re remuneration policy
Macau Property Opportunities Fund LtdAGM
Softcat PLCAGM
Spectris PLCGM re remuneration policy
Wednesday 14 December 
Fidelity Special Values PLCAGM
Kistos PLCGM re new non-operational entity
Parsley Box Group PLCGM re proposal to become a private limited company
TP Group PLCGM re cash acquisition
Volution Group PLCAGM
Westpac Banking CorpAGM
Thursday 15 December 
Aeorema Communications PLCAGM
Argos Resources LtdAGM
Baillie Gifford Japan Trust PLCAGM
Capricorn Energy PLCGM re proposed share premium account cancellation
Chelverton Growth Trust PLCAGM
CQS Natural Resources Growth & Income PLCAGM
DX Group PLCAGM
DXS International PLCAGM
Glenveagh Properties PLCEGM
Secured Income Fund PLCGM re proposed reduction of capital
Schroder Income Growth Fund PLCAGM
Friday 16 December 
Bellway PLCAGM
Inchcape PLCGM re Derco acquisition
JPMorgan Global Growth & Income PLCGM re proposed combination with JPMorgan Elect PLC
National Australia Bank LtdAGM
Sareum Holdings PLCAGM
Thor Explorations LtdAGM
UP Global Sourcing Holdings PLCAGM
  
Copyright 2022 Alliance News Ltd. All Rights Reserved.

Read more
21 Nov 2022 12:44

IN BRIEF: Sareum salutes publication of SRA737 combination trial data

Sareum Holdings PLC - Cambridge, England-based biotechnology company focused on developing kinase inhibitors for autoimmune disease & cancer - Says it is pleased by the publication of data from the Phase 1/2 trial of SRA737 as a combination treatment for advanced cancers in the medical journal, Clinical Cancer Research.

Read more
24 Oct 2022 10:28

IN BRIEF: Sareum widens annual loss; considers future of SRA737

Sareum Holdings PLC - Cambridge, England-based drug developer for cancer and autoimmune diseases - In the year ended June 30, pretax loss widens to GBP2.6 million from GBP1.7 million a year before. No revenue is recorded in either year, but in the previous year it brought in GBP171,000 in other operating income, with none recorded for financial 2022. Says it will discuss the future of SRA737 with partner Cancer Research Technology Pioneer Fund. Earlier this month, GSK PLC subsidiary Sierra Oncology Inc said it intends to return the rights for the SRA737 cancer treatment to CPF.

Read more
12 Oct 2022 10:47

Sareum plunges as GSK subsidiary Sierra returns rights for SRA737

(Alliance News) - Sareum Holdings PLC on Wednesday after Sierra Oncology Inc, a subsidiary of GSK PLC, said it intends to return the rights for SRA737 to the CRT Pioneer Fund LP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.